APA (7th ed.) Citation

D, S., SP, W., MP, G., Y, Z., FT, B., GF, K., . . . M, P. (2021). Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals. MSphere, 6(4), e0057121. https://doi.org/10.1128/mSphere.00571-21

Chicago Style (17th ed.) Citation

D, Stelitano, et al. "Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals." MSphere 6, no. 4 (2021): e0057121. https://doi.org/10.1128/mSphere.00571-21.

MLA (9th ed.) Citation

D, Stelitano, et al. "Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals." MSphere, vol. 6, no. 4, 2021, p. e0057121, https://doi.org/10.1128/mSphere.00571-21.